These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 16882693
1. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin. Franco P, Vocca I, Carriero MV, Alfano D, Cito L, Longanesi-Cattani I, Grieco P, Ossowski L, Stoppelli MP. J Cell Sci; 2006 Aug 15; 119(Pt 16):3424-34. PubMed ID: 16882693 [Abstract] [Full Text] [Related]
2. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli MP. Cancer Res; 1999 Oct 15; 59(20):5307-14. PubMed ID: 10537314 [Abstract] [Full Text] [Related]
3. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Tarui T, Akakura N, Majumdar M, Andronicos N, Takagi J, Mazar AP, Bdeir K, Kuo A, Yarovoi SV, Cines DB, Takada Y. Thromb Haemost; 2006 Mar 15; 95(3):524-34. PubMed ID: 16525582 [Abstract] [Full Text] [Related]
4. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. Nip J, Rabbani SA, Shibata HR, Brodt P. J Clin Invest; 1995 May 15; 95(5):2096-103. PubMed ID: 7537755 [Abstract] [Full Text] [Related]
5. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Salasznyk RM, Zappala M, Zheng M, Yu L, Wilkins-Port C, McKeown-Longo PJ. Matrix Biol; 2007 Jun 15; 26(5):359-70. PubMed ID: 17344041 [Abstract] [Full Text] [Related]
6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T. BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015 [Abstract] [Full Text] [Related]
7. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice. Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG. J Cell Physiol; 2005 Jul 20; 204(1):73-82. PubMed ID: 15573379 [Abstract] [Full Text] [Related]
8. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Magdolen V, Bürgle M, de Prada NA, Schmiedeberg N, Riemer C, Schroeck F, Kellermann J, Degitz K, Wilhelm OG, Schmitt M, Kessler H. Biol Chem; 2001 Aug 20; 382(8):1197-205. PubMed ID: 11592401 [Abstract] [Full Text] [Related]
9. Regulation of urokinase receptor function and pericellular proteolysis by the integrin alpha(5)beta(1). Bass R, Ellis V. Thromb Haemost; 2009 May 20; 101(5):954-62. PubMed ID: 19404550 [Abstract] [Full Text] [Related]
10. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect. Maupas-Schwalm F, Bedel A, Augé N, Grazide MH, Mucher E, Thiers JC, Salvayre R, Nègre-Salvayre A. Cell Signal; 2009 Dec 20; 21(12):1925-34. PubMed ID: 19735728 [Abstract] [Full Text] [Related]
11. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ, Lee SW, Dichek DA, Ellis V. J Pept Sci; 2000 Sep 20; 6(9):432-9. PubMed ID: 11016879 [Abstract] [Full Text] [Related]
12. Vitronectin binding to urokinase receptor in human breast cancer. Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M. Clin Cancer Res; 1997 Aug 20; 3(8):1299-308. PubMed ID: 9815812 [Abstract] [Full Text] [Related]
13. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Reuning U, Magdolen V, Hapke S, Schmitt M. Biol Chem; 2003 Aug 20; 384(8):1119-31. PubMed ID: 12974381 [Abstract] [Full Text] [Related]
14. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. Tarui T, Andronicos N, Czekay RP, Mazar AP, Bdeir K, Parry GC, Kuo A, Loskutoff DJ, Cines DB, Takada Y. J Biol Chem; 2003 Aug 08; 278(32):29863-72. PubMed ID: 12754207 [Abstract] [Full Text] [Related]
15. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Yebra M, Goretzki L, Pfeifer M, Mueller BM. Exp Cell Res; 1999 Jul 10; 250(1):231-40. PubMed ID: 10388537 [Abstract] [Full Text] [Related]
16. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. EMBO J; 1997 Dec 15; 16(24):7279-86. PubMed ID: 9405357 [Abstract] [Full Text] [Related]
17. Structure and function of the urokinase receptor. Mondino A, Resnati M, Blasi F. Thromb Haemost; 1999 Sep 15; 82 Suppl 1():19-22. PubMed ID: 10695480 [Abstract] [Full Text] [Related]
19. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation. Ploug M, Ostergaard S, Hansen LB, Holm A, Danø K. Biochemistry; 1998 Mar 17; 37(11):3612-22. PubMed ID: 9521680 [Abstract] [Full Text] [Related]
20. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen. Ellis V, Whawell SA, Werner F, Deadman JJ. Biochemistry; 1999 Jan 12; 38(2):651-9. PubMed ID: 9888805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]